Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Dermatology

Search Medical Condition
Please enter condition
Please choose location from dropdown

Hidradenitis Suppurativa Clinical Trials

A listing of Hidradenitis Suppurativa medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (20) clinical trials

Primary end point: To evaluate the safety and tolerability of INCB054707. Secondary end point: To evaluate the systemic exposure and evaluate the efficacy of INCB054707. Overall design: This is a Phase 2, multicenter, open-label, single-arm study to assess the safety of 15 mg QD INCB054707 over 8 weeks in men and women aged 18 ...

Phase

Primary end point: To determine the safety and tolerability of INCB054707. Key Secondary end point: To determine the systemic exposure to INCB054707 and to determine the efficacy of INCB054707. Overall design: Population: Men and women aged 18 to 75 years with moderate to severe HS for at least 6 months. ...

Phase

A National Registry For Patients With Hidradenitis Suppurativa

The goal of this study is to get a better understanding of the skin condition, Hidradenitis Suppurativa, and to find out how the disease affects quality of life. Through internet groups and the American Academy of Dermatology, we propose to enroll greater than 200 enrollees in the first two years ...

Phase N/A

Effect of Sclerotherapy on Fistulas and Sinus Tracts in Hidradenitis Suppurativa

This study evaluates the effect of hypertonic saline 23.4% injection in fistulas or sinus tracts in adult patients with hidradenitis suppurativa.

Phase

Exploratory Trial Evaluating Cosentyx (Secukinumab) for Patients With Moderate-to-Severe Hidradenitis Suppurativa

Secukinumab is an antibody that inhibits Interleukin-17A, and IL-17 promotes neutrophil activities. Neutrophils are found in large numbers in HS. The expression of the inflammatory cytokines IL-17, IL-1, and TNF- were enhanced in lesional skin of HS patients. Prior studies have demonstrated improvement in HS with biologic medications such as ...

Phase N/A

Group Psychotherapy for Patients With Hidradenitis Suppurativa: Effects in Quality of Life

Further investigations studies are needed to determine the efficacy of psychological interventions for people with hidradenitis suppurativa. The aim of this study is to determine the benefits of group psychotherapy on quality of life for people with hidradenitis suppurativa receiving medical and surgical treatment versus a control group (awaiting group) ...

Phase N/A

Wound Etiology and Healing Study

The purpose of the WE-HEAL Study is to help researchers use human tissue samples and health records to study the reasons why some patients heal quickly and some have problems healing wounds. All patients seen with an open wound or hidradenitis suppurativa are invited to participate. Information from this research ...

Phase N/A

Treatment of Hidradenitis Suppurativa With Eth 755nm Alexandrite Laser

Patients with bilateral disease will be chosen to participate in the study. Patients will be advised to discontinue any prior systemic HS treatments two weeks before their first laser session as a wash out period. One side of the patient will be chosen as the treatment side, the other as ...

Phase N/A

The Ohio State University Dermatology Biorepository Molecular Biology and Genetics of Hidradenitis Suppurativa

A variety of molecular techniques can be used to investigate diseases by analyzing protein, DNA, and RNA. Flow cytometry, PCR, histology and immunohistochemistry are assays which can identify specific cell populations and provide valuable information regarding the pathologic characteristics of those populations. Flow cytometry analyzes the surface markers of cells. ...

Phase N/A

Impact of Hidradenitis Suppurativa on Quality of Life Functions

The goal of this study is to get a better understanding of the impact of the skin condition, Hidradenitis Suppurativa, on quality of life function of patients with this condition. Patients with HS will be asked questions about demographics including gender, age, and ethnicity. They will also be asked to ...

Phase N/A